Lexicon Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: LXRX
Share price (6/3/26): $1.85
Market cap (6/3/26): $822 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Exempt offering of securities

Free writing prospectus

Prospectus supplement for primary offering

Free writing prospectus

Free writing prospectus

Ownership Filter

Artal Group S.A., Artal International S.C.A., Westend S.A., Stichting Administratiekantoor Westend, Artal International Management S.A., Wittouck Amaury, Artal Participations S.a r.l.

Invus Global Management, LLC

Amouyal Philippe

Sobecki Christopher J

News Filter

Reports First Quarter 2026 Financial Results and Provides Clinical Updates

Announces $100 Million Loan Facility With Hercules Capital

Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates

Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC